FDA Approved: IDOSE TR — Supplemental Application (Glaukos Corporation)

View source ↗

Summary

FDA approved a supplemental application for IDOSE TR, a travoprost intracameral product from Glaukos Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• IDOSE TR (travoprost intracameral)

Snippet

SUPPL AP for IDOSE TR (TRAVOPROST INTRACAMERAL)